| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 121.33B | 119.01B | 104.78B | 97.34B | 97.97B | 80.99B |
| Gross Profit | 57.23B | 56.19B | 48.83B | 42.79B | 42.87B | 34.87B |
| EBITDA | 24.69B | 24.94B | 21.73B | 23.71B | 25.20B | 21.08B |
| Net Income | 10.81B | 10.78B | 8.65B | 11.40B | 11.80B | 9.53B |
Balance Sheet | ||||||
| Total Assets | 187.61B | 192.02B | 212.75B | 187.26B | 189.27B | 179.00B |
| Cash, Cash Equivalents and Short-Term Investments | 36.54B | 44.90B | 58.58B | 47.12B | 51.56B | 54.70B |
| Total Debt | 62.16B | 64.52B | 86.72B | 71.50B | 78.15B | 81.22B |
| Total Liabilities | 87.64B | 89.04B | 112.35B | 94.52B | 103.80B | 102.50B |
| Stockholders Equity | 99.96B | 102.97B | 100.39B | 92.74B | 85.47B | 76.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 17.40B | 9.64B | 11.07B | 9.17B | 12.23B |
| Operating Cash Flow | 0.00 | 23.71B | 21.22B | 22.74B | 18.31B | 16.31B |
| Investing Cash Flow | 0.00 | -8.31B | -21.07B | -13.16B | -11.26B | -11.60B |
| Financing Cash Flow | 0.00 | -29.22B | 8.95B | -13.94B | -11.28B | 19.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥604.30B | 20.62 | ― | 3.26% | 11.78% | 8.98% | |
69 Neutral | ¥2.35T | 13.66 | 11.64% | 1.52% | 9.81% | 32.64% | |
68 Neutral | ¥414.98B | 7.90 | 13.71% | 3.38% | 0.29% | 27.84% | |
67 Neutral | ¥784.70B | 77.75 | -2.50% | 3.49% | -6.83% | -123.67% | |
65 Neutral | ¥361.21B | 10.69 | 8.14% | 2.61% | -1.45% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥752.63B | 12.79 | 2.01% | 3.82% | -4.63% | -65.11% |